US Patent Number
Pharmaceutical compounds comprising bridged nicotine analogs of N-octylnicotinium iodide (NONI) having selective antagonist properties at α3β2-containing nicotinic receptor subtypes, and compositions containing these compounds. The compounds and compositions are used to treat central nervous system pathologies.
University of Kentucky Research Foundation, Lexington, KY (US)
Crooks, Peter A.; Dwoskin, Linda P.; Xu, Rui; and Grinevich, Vladimir P., "Bridged Nicotine Compounds for Use in the Treatment of CNS Pathologies" (2003). Pharmaceutical Sciences Faculty Patents. 71.